---
figid: PMC9406168__cancers-14-03854-g006
figtitle: Integrative, In Silico and Comparative Analysis of Breast Cancer Secretome
  Highlights Invasive-Ductal-Carcinoma-Grade Progression Biomarkers
organisms:
- NA
pmcid: PMC9406168
filename: cancers-14-03854-g006.jpg
figlink: /pmc/articles/PMC9406168/figure/cancers-14-03854-f006/
number: F6
caption: 'Proposed mechanism by which hierarchical secretion of identified secretome
  proteins may lead to the progression from grade I and II to grade III breast cancer
  Proteins in bold belong to the overlapping protein cluster as shown in . Blue cell
  (grade I and II, Cluster 1) interactions: LAMB1-3, LAMC1, COL7A, and AGRN interactions
  with ITGB1 [,]. Downstream activation of JNK and ERK cascades through ITGB1 [,].
  Parallel activation of the ERK cascade by EGF-EGFR interaction []. FBN1 interaction
  with VEGFR1 and downstream STAT2 activation []. BMP interaction with BMPR and subsequent
  activation of SMAD 1/5/8 []. Downstream effectors of JNK and ERK cascade []. Brown
  cell (grade III, cluster 2) interactions: HSPG2 and LOXL2 interaction with IGFB3
  [,]. Laminin protein family interaction with MET and ITGB1 [,]. ACTG1 interaction
  with THBS1, LTBP1, fibronectin, and LOXL to drive SDC4 phosphorylation and subsequent
  WNT pathway activation [,,,,]. LDLR laminin interaction and internalization leads
  to PCSK9 activation and tumor microenvironment promotion []. VEGFA-VEGFR2 interaction
  promotes the ERK cascade activation []. IGFBP-3, fibrillin, and ERK cascade leads
  activation of TGF-beta [,]. Integrin-beta1-dependent activation of MET []. mTOR
  downstream effectors []. TGFβ genetic targets []. Wnt and b-catenin downstream genetic
  targets []. Image created with BioRender.com. Protein name abbreviations stated
  in .'
papertitle: Integrative, In Silico and Comparative Analysis of Breast Cancer Secretome
  Highlights Invasive-Ductal-Carcinoma-Grade Progression Biomarkers.
reftext: Stavroula L. Kastora, et al. Cancers (Basel). 2022 Aug;14(16):3854.
year: '2022'
doi: 10.3390/cancers14163854
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: bioinformatics | comparative analysis | IDC | biomarkers
automl_pathway: 0.9591653
figid_alias: PMC9406168__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9406168__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9406168__cancers-14-03854-g006.html
  '@type': Dataset
  description: 'Proposed mechanism by which hierarchical secretion of identified secretome
    proteins may lead to the progression from grade I and II to grade III breast cancer
    Proteins in bold belong to the overlapping protein cluster as shown in . Blue
    cell (grade I and II, Cluster 1) interactions: LAMB1-3, LAMC1, COL7A, and AGRN
    interactions with ITGB1 [,]. Downstream activation of JNK and ERK cascades through
    ITGB1 [,]. Parallel activation of the ERK cascade by EGF-EGFR interaction [].
    FBN1 interaction with VEGFR1 and downstream STAT2 activation []. BMP interaction
    with BMPR and subsequent activation of SMAD 1/5/8 []. Downstream effectors of
    JNK and ERK cascade []. Brown cell (grade III, cluster 2) interactions: HSPG2
    and LOXL2 interaction with IGFB3 [,]. Laminin protein family interaction with
    MET and ITGB1 [,]. ACTG1 interaction with THBS1, LTBP1, fibronectin, and LOXL
    to drive SDC4 phosphorylation and subsequent WNT pathway activation [,,,,]. LDLR
    laminin interaction and internalization leads to PCSK9 activation and tumor microenvironment
    promotion []. VEGFA-VEGFR2 interaction promotes the ERK cascade activation [].
    IGFBP-3, fibrillin, and ERK cascade leads activation of TGF-beta [,]. Integrin-beta1-dependent
    activation of MET []. mTOR downstream effectors []. TGFβ genetic targets []. Wnt
    and b-catenin downstream genetic targets []. Image created with BioRender.com.
    Protein name abbreviations stated in .'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FBN1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KDR
  - LGALS3BP
  - LAMB3
  - LAMC1
  - LAMB1
  - LAMB2
  - LMNB2
  - AGRN
  - ITGB1
  - BMP1
  - BMP2
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - IGFBP3
  - COL7A1
  - NEUROD1
  - TUBB4B
  - EEF1B2P2
  - BHLHE22
  - LAMC2
  - SMAD1
  - GARS1
  - SMAD5
  - SMAD9
  - MYC
  - ELK1
  - KCNH4
  - KCNH8
  - MAX
  - MAPK8
  - MAPK9
  - MAPK10
  - SMAD4
  - SP1
  - PSG1
  - DAND5
  - HSPG2
  - CTSL
  - CTSV
  - LOXL2
  - ME2
  - CELSR1
  - PCDHB11
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - GDNF
  - PLAU
  - CTNNB1
  - CCND1
  - ASCL2
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - HIF1A
  - SETD2
  - ARNT
  - STAT3
  - JUN
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TAFAZZIN
  - WWTR1
  - YAP1
  - LTBP1
  - EGFR
  - SDC4
  - TGFBI
  - LDLR
  - ACTG1
  - EPHB2
  - MAPK1
  - MAPK3
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - THBS1
  - VEGFA
  - DAG1
  - FN1
  - LAMA5
  - GPC1
  - THBS2
  - THBS3
  - THBS4
  - COMP
  - PCSK9
  - FZD7
  - ITK
  - SLC22A3
---
